Symbol="PRQR"
AssetType="Common Stock"
Name="ProQR Therapeutics BV"
Description="ProQR Therapeutics NV, a biopharmaceutical company, is dedicated to the discovery and development of RNA-based therapies for the treatment of genetic disorders. The company is headquartered in Leiden, the Netherlands."
CIK="1612940"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="ZERNIKEDREEF 9, LEIDEN, NL"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="123832000"
EBITDA="-49274000"
PERatio="None"
PEGRatio="0"
BookValue="0.64"
DividendPerShare="0"
DividendYield="0"
EPS="-0.85"
RevenuePerShareTTM="0.059"
ProfitMargin="0"
OperatingMarginTTM="-11.16"
ReturnOnAssetsTTM="-0.191"
ReturnOnEquityTTM="-0.782"
RevenueTTM="4482000"
GrossProfitTTM="4802000"
DilutedEPSTTM="-0.85"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.208"
AnalystTargetPrice="3.92"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="29.24"
PriceToBookRatio="1.702"
EVToRevenue="9.84"
EVToEBITDA="-0.502"
Beta="0.0003"
num_52WeekHigh="3.85"
num_52WeekLow="0.722"
num_50DayMovingAverage="1.639"
num_200DayMovingAverage="2.139"
SharesOutstanding="80936000"
DividendDate="None"
ExDividendDate="None"
symbol="PRQR"
open="1.54"
high="1.54"
low="1.50"
price="1.52"
volume="162088.00"
latest_trading_day="2023-08-17"
previous_close="1.53"
change="-0.01"
change_percent="-0.6536%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="98"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="2"
Volume_recent_avg="512729"
Change_recent_avg="-0.01"
Delta_recent_avg="0.12"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-0.79"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="2"
Aroon_momentum_negative="98"
image_negative_thumbnail_id_1="1148"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0181.jpeg"
image_negative_thumbnail_id_2="95"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0081.jpeg"
image_neutral_thumbnail_id_1="577"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0022.jpeg"
image_neutral_thumbnail_id_2="563"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0036.jpeg"
image_positive_thumbnail_id_1="981"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0143.jpeg"
image_positive_thumbnail_id_2="611"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0097.jpeg"
image_professor_thumbnail_id_1="1183"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
image_professor_thumbnail_id_2="1169"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
